Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-07

Study Completion Date

2017-02-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine whether an existing treatment for problems that participants have with making movements after a stroke can be performed at home.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Mirror Therapy and Task Oriented Training for Persons With Paretic Upper Extremity

NCT02917343

Stroke Cerebrovascular Accident

COMPLETED NA

Use of Tendon Vibration and Mirror for the Improvement of Upper Limb Function and Pain Reduction

NCT01010607

Stroke Hemiplegia

UNKNOWN PHASE1/PHASE2

Feasibility of Real-Time Visual Feedback in Augmented Reality to Reduce Gait Asymmetry Post-Stroke

NCT07178535

Stroke

NOT_YET_RECRUITING NA

Comparison of Two Rehabilitation Strategies in Patients With Hemiparesis One Year or More After Stroke

NCT02202954

Hemiparesis

UNKNOWN NA

Retraining the Walking Pattern After Stroke

NCT03813342

Stroke Hemiparesis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will compare two forms of home-based treatment for post-stroke problems making movements with the arms and hands. After initial pre-treatment assessments, participants will complete 4 weeks of treatment, with assessments after each week of treatment and 3 months after the completion of treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiparesis Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mirror therapy

4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.

Group Type EXPERIMENTAL

Mirror therapy

Intervention Type BEHAVIORAL

A home-based therapy involving mirrored visual feedback

Divider therapy

4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.

Group Type ACTIVE_COMPARATOR

Divider therapy

Intervention Type BEHAVIORAL

A home-based therapy involving removed visual feedback.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mirror therapy

A home-based therapy involving mirrored visual feedback

Intervention Type BEHAVIORAL

Divider therapy

A home-based therapy involving removed visual feedback.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 6 months or more post-stroke
* upper extremity Fugl-Meyer score between 10 and 50
* no longer participating in upper-extremity physical or occupational therapy
* sufficient comprehension ability to understand instructions

Exclusion Criteria

* previous head trauma, psychiatric illness or chronic exposure to medications that might be expected to have lasting consequences for the central nervous system (e.g., haloperidol, dopaminergics)
* dementia

Minimum Eligible Age

21 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No